Your browser doesn't support javascript.
loading
Evaluation of the efficacy and safety of oral N-acetylcysteine in patients with COVID-19 receiving the routine antiviral and hydroxychloroquine protocol: A randomized controlled clinical trial.
Atefi, Najmolsadat; Goodarzi, Azadeh; Riahi, Taghi; Khodabandehloo, Niloofar; Talebi Taher, Mahshid; Najar Nobari, Niloufar; Seirafianpour, Farnoosh; Mahdi, Zeinab; Baghestani, Amir; Valizadeh, Rohollah.
Afiliación
  • Atefi N; Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Goodarzi A; Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Riahi T; Department of Internal Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Khodabandehloo N; Department of Geriatric Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Talebi Taher M; Department of Infectious Disease, School of Medicine, Antimicrobial Resistance Research Center, Immunology and Infectious Disease Research Institute, Iran University of Medical Sciences, Tehran, Iran.
  • Najar Nobari N; Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Seirafianpour F; Razi Drug Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Mahdi Z; Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Baghestani A; Department of General Medicine, Rasool Akram Medical Complex, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Valizadeh R; Urmia University of Medical Sciences, Urmia, Iran.
Immun Inflamm Dis ; 11(11): e1083, 2023 Nov.
Article en En | MEDLINE | ID: mdl-38018602
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_covid_19 / 4_pneumonia / 6_other_respiratory_diseases Asunto principal: Ritonavir / COVID-19 Límite: Humans Idioma: En Revista: Immun Inflamm Dis Año: 2023 Tipo del documento: Article País de afiliación: Irán
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_covid_19 / 4_pneumonia / 6_other_respiratory_diseases Asunto principal: Ritonavir / COVID-19 Límite: Humans Idioma: En Revista: Immun Inflamm Dis Año: 2023 Tipo del documento: Article País de afiliación: Irán